Grade 6/9 School-Based Immunization

Grade 6

The Yukon Immunization Schedule recommends that Grade 6 students receive the Human Papillomavirus (HPV) immunization.

Grade 6 Consent Form [English] [French]

Grade 6 Immunization Manual [English] [French]


Grade 9

The Yukon Immunization Schedule recommends that Grade 9 students receive: Tetanus, Diphtheria, Pertussis (Tdap) booster and Meningococcal Quadrivalent immunization. 

Grade 9 Consent Form [English] [French]

Grade 9 Immunization Manual [English] [French]  


The Tdap immunizations are provided at no cost as part of your child’s routine immunizations. The routine Yukon Immunization Program is based on the recommendations of the Canadian Advisory Committee on Immunizations and is recommended by the Territorial Advisory Committee on Immunizations, and Yukon’s Chief Medical Officer of Health, Dr. Brendan Hanley.

Tetanus Diphtheria and Pertussis (Tdap)
A Tdap immunization given in Grade 9 boosts immunity to tetanus, diphtheria and pertussis from immunizations that were received in childhood. This dose is needed to help previous immunizations against these three diseases keep working. After this immunization, most people only need to receive tetanus and diphtheria boosters every 10 years. An immunization against tetanus, diphtheria and pertussis is the best way to protect your child against these serious and sometimes fatal infections.

Tetanus, also called "lockjaw", is caused by a germ or bacteria mostly found in the soil. When the bacteria enter the skin through a cut or scrape, they produce a poison that can cause painful tightening of muscles all over the body. It is very serious if the breathing muscles are affected. Up to two in 10 people who get tetanus die of it.

Diphtheria is a serious infection of the nose and throat. About one in 10 people who get diphtheria will die. The germ or bacteria are spread through the air by persons sneezing or coughing and by direct skin-to-skin contact. The disease can result in very severe breathing problems. It can also cause heart failure and paralysis.

Pertussis, or "whooping cough", is a serious infection of the lungs and throat. Each year in Canada, one to three deaths occur due to pertussis, primarily in babies. The germs or bacteria are easily spread through coughing, sneezing, or close face-to-face contact.

Pertussis can cause severe coughing that often ends with a whooping sound before the next breath. This cough can last several months and occurs more often at night. Pertussis can also cause pneumonia, convulsions, brain damage or death. These severe complications are seen most often in babies; however, older children and adults with pertussis often spread it to babies who are too young to be fully protected by the immunization.

There have been many pertussis outbreaks across many provinces and territories in Canada and the USA in the past three years.

Meningococcal Quadrivalent (Men C-ACYW-135)

The majority of invasive meningococcal disease (IDM) is associated with Neisseria meningitides (meningococcus). It is a serious and life-threatening infection including:

  • Meningitis, which is an infection of the lining that covers the brain, and
  • Septicemia, which is an infection of the blood.

These are life-threatening infections. Permanent complications of infection include brain damage, deafness, and loss of limbs. Meningococcal infection can be spread from one person to another through respiratory contact (coughing, sneezing, or close face to face contact) or through saliva (kissing, sharing of food, drink, mouth guards, water bottles, or other items in contact with saliva). Immunization is the best prevention against Meningococcal infections.

Meningococcal Quadrivalent Conjugate vaccine provides protection against illness caused by serogroups A,C,Y,W-135 strains of meningococcus. It does not protect against other strains of this bacteria. It does not protect against other organisms that cause meningitis or septicemia. The vaccine is given in a single needle.

This vaccine is being offered because the disease it prevents can be very serious. Since 2011, the Yukon Immunization Schedule has recommended that children receive the monovalent vaccine (Men C) when they are two months old and 12 months old. The meningococcal quadrivalent offered in grade 9, will cover three more strains than the vaccine offered for the infant series.